These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3124166)
41. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia. Leong OK; Wong KE; Tay WK; Gill RC Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796 [TBL] [Abstract][Full Text] [Related]
42. Follow-up study of 281 schizophrenic patients treated with high dosage fluphenazine decanoate. Steiner S; Nagy C Int Pharmacopsychiatry; 1981; 16(3):184-92. PubMed ID: 7319750 [TBL] [Abstract][Full Text] [Related]
43. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs. Dreyfuss J; Shaw JM; Ross JJ J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144 [TBL] [Abstract][Full Text] [Related]
44. Low dose fluphenazine decanoate in maintenance treatment of schizophrenia. Kane JM; Rifkin A; Quitkin F; Nayak D; Saraf K; Ramos-Lorenzi JR; Klein DF; Sachar EJ Psychiatry Res; 1979 Dec; 1(3):341-8. PubMed ID: 233160 [TBL] [Abstract][Full Text] [Related]
45. Clinical pharmacokinetics of the depot antipsychotics. Jann MW; Ereshefsky L; Saklad SR Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156 [TBL] [Abstract][Full Text] [Related]
46. Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate. Marder SR; Hubbard JW; Van Putten T; Hawes EM; McKay G; Mintz J; May PR; Midha KK Psychopharmacol Bull; 1986; 22(1):264-6. PubMed ID: 3726072 [No Abstract] [Full Text] [Related]
47. [Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)]. Lehmann E; Quadbeck H; Tegeler J; Fararuni M; Heinrich K Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):117-29. PubMed ID: 7393998 [TBL] [Abstract][Full Text] [Related]
50. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks. Carpenter WT; Buchanan RW; Kirkpatrick B; Lann HD; Breier AF; Summerfelt AT Am J Psychiatry; 1999 Mar; 156(3):412-8. PubMed ID: 10080557 [TBL] [Abstract][Full Text] [Related]
51. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients. Walker CA Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287 [TBL] [Abstract][Full Text] [Related]
53. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia. Kong DS; Yeo SH Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894 [TBL] [Abstract][Full Text] [Related]
59. Fluphenazine determination in human plasma by a sensitive gas chromatographic method using nitrogen detector. Javaid JI; Dekirmenjian H; Liskevych U; Lin RL; Davis JM J Chromatogr Sci; 1981 Sep; 19(9):439-43. PubMed ID: 7298790 [TBL] [Abstract][Full Text] [Related]
60. A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia. Russell N; Landmark J; Merskey H; Turpin T Can J Psychiatry; 1982 Nov; 27(7):593-6. PubMed ID: 7172160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]